167 related articles for article (PubMed ID: 16127553)
21. Effects of propranolol on symptom and endocrine responses to pentagastrin.
Khan S; Liberzon I; Abelson JL
Psychoneuroendocrinology; 2004 Oct; 29(9):1163-71. PubMed ID: 15219640
[TBL] [Abstract][Full Text] [Related]
22. Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic review.
Garcia de Miguel B; Nutt DJ; Hood SD; Davies SJ
J Psychopharmacol; 2012 Apr; 26(4):431-42. PubMed ID: 20643698
[TBL] [Abstract][Full Text] [Related]
23. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
24. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820
[TBL] [Abstract][Full Text] [Related]
25. Prolactin but not ACTH increases during sodium lactate-induced panic attacks.
Otte C; Kellner M; Arlt J; Jahn H; Holsboer F; Wiedemann K
Psychiatry Res; 2002 Mar; 109(2):201-5. PubMed ID: 11927145
[TBL] [Abstract][Full Text] [Related]
26. alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity.
Pasquali R; Vicennati V; Calzoni F; Gnudi U; Gambineri A; Ceroni L; Cortelli P; Menozzi R; Sinisi R; Rio GD
Clin Endocrinol (Oxf); 2000 Apr; 52(4):413-21. PubMed ID: 10762283
[TBL] [Abstract][Full Text] [Related]
27. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.
Curtis GC; Abelson JL; Gold PW
Biol Psychiatry; 1997 Jan; 41(1):76-85. PubMed ID: 8988798
[TBL] [Abstract][Full Text] [Related]
28. Relationship between respiratory, endocrine, and cognitive-emotional factors in response to a pharmacological panicogen.
Lyubkin M; Giardino ND; Abelson JL
Depress Anxiety; 2010 Nov; 27(11):1011-6. PubMed ID: 20721903
[TBL] [Abstract][Full Text] [Related]
29. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
Coplan JD; Pine DS; Papp LA; Gorman JM
Psychopharmacol Bull; 1997; 33(2):193-204. PubMed ID: 9230631
[No Abstract] [Full Text] [Related]
30. Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking.
Garcia-Leal C; Parente AC; Del-Ben CM; Guimarães FS; Moreira AC; Elias LL; Graeff FG
Psychiatry Res; 2005 Feb; 133(2-3):239-52. PubMed ID: 15740999
[TBL] [Abstract][Full Text] [Related]
31. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
Zwanzger P; Eser D; Aicher S; Schüle C; Baghai TC; Padberg F; Ella R; Möller HJ; Rupprecht R
Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
[TBL] [Abstract][Full Text] [Related]
32. Psychoimmunoendocrine aspects of panic disorder.
Brambilla F; Bellodi L; Perna G; Battaglia M; Sciuto G; Diaferia G; Petraglia F; Panerai A; Sacerdote P
Neuropsychobiology; 1992; 26(1-2):12-22. PubMed ID: 1335559
[TBL] [Abstract][Full Text] [Related]
33. Similarities in hypothalamic-pituitary-adrenal axis activity between patients with panic disorder and those experiencing external stress.
Kathol RG; Noyes R; Lopez A
Psychiatr Clin North Am; 1988 Jun; 11(2):335-48. PubMed ID: 3047703
[TBL] [Abstract][Full Text] [Related]
34. [Stress and psychotic transition: A literature review].
Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
[TBL] [Abstract][Full Text] [Related]
35. Stress response regulation in panic disorder.
Ising M; Höhne N; Siebertz A; Parchmann AM; Erhardt A; Keck M
Curr Pharm Des; 2012; 18(35):5675-84. PubMed ID: 22632473
[TBL] [Abstract][Full Text] [Related]
36. Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin.
Khan S; Liberzon I; Abelson JL
Psychiatry Res; 2004 May; 126(3):189-95. PubMed ID: 15157745
[TBL] [Abstract][Full Text] [Related]
37. CO2 challenge induced HPA axis activation in panic.
van Duinen MA; Schruers KR; Maes M; Griez EJ
Int J Neuropsychopharmacol; 2007 Dec; 10(6):797-804. PubMed ID: 17076937
[TBL] [Abstract][Full Text] [Related]
38. A pilot study of noradrenergic and HPA axis functioning in PTSD vs. panic disorder.
Marshall RD; Blanco C; Printz D; Liebowitz MR; Klein DF; Coplan J
Psychiatry Res; 2002 Jul; 110(3):219-30. PubMed ID: 12127472
[TBL] [Abstract][Full Text] [Related]
39. Copeptin response to panic provocation with CO
Müller JC; Walter C; Leibold N; Wiedemann K; Kellner M; Demiralay C
J Psychiatr Res; 2023 Sep; 165():225-232. PubMed ID: 37517243
[TBL] [Abstract][Full Text] [Related]
40. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
Ströhle A; Holsboer F; Rupprecht R
Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
